It also indicated that the mRNA expression levels of FBXO20 and FBXO45 were closely related to the tumor stage of PDAC patients (Supplementary Figure S5B), which meant that patients who were in more advanced tumor staging tended to express higher transcripts of FBXO20, FBXO32, and FBXO45. This evidence concerns the gene FBXO45 and neoplasm.